Literature DB >> 8382263

Release-regulating serotonin 5-HT1D autoreceptors in human cerebral cortex.

G Maura1, S Thellung, G C Andrioli, A Ruelle, M Raiteri.   

Abstract

Release-regulating 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain belong to the 5-HT1B subtype. On the other hand, the human brain seems to lack 5-HT1B receptors. In the present work 5-HT autoreceptors present in human brain were characterized pharmacologically. Synaptosomes prepared from biopsy samples of human neocortex were labeled with [3H]5-HT and exposed in superfusion to selective 5-HT receptor agonists and antagonists during K+ depolarization. The rank order of potency of agonists as inhibitors of the [3H]5-HT overflow was 5-HT > sumatriptan (5-HT1D/1B) > 8-hydroxy-2-(di-n-propylamino)tetralin (5-HT1A/1D) >> 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (5-HT2/1C). The effect of 5-HT was insensitive to ketanserin (5-HT2) but antagonized by methiothepin (5-HT1/2) or by metergoline (5-HT1C/1D). The data are compatible with a classification of the human 5-HT autoreceptor as being of the 5-HT1D subtype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382263     DOI: 10.1111/j.1471-4159.1993.tb03274.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.

Authors:  M Bühlen; K Fink; C Böing; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

2.  Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex.

Authors:  Benjamin Berger; Anna Katharina Rothmaier; Franziska Wedekind; Josef Zentner; Thomas J Feuerstein; Rolf Jackisch
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

3.  Functional characterization of the 5-HT terminal autoreceptor in the guinea-pig brain cortex.

Authors:  C Roberts; J Watson; M Burton; G W Price; B J Jones
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

4.  Presynaptic inhibitory serotonin autoreceptors in the human hippocampus.

Authors:  E Schlicker; K Fink; J Zentner; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

5.  Pharmacological characterizations of recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes coupled to adenylate cyclase inhibition in clonal cell lines: apparent differences in drug intrinsic efficacies between human 5-HT1D subtypes.

Authors:  J M Zgombick; L E Schechter; N Adham; S A Kucharewicz; R L Weinshank; T A Branchek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

6.  Pharmacological diversity between native human 5-HT1B and 5-HT1D receptors sited on different neurons and involved in different functions.

Authors:  M Marcoli; G Maura; C Munari; A Ruelle; M Raiteri
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

7.  Functional characterization of 5-HT1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex.

Authors:  M el Mansari; P Blier
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

8.  Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats.

Authors:  H Sershen; A Hashim; A Lajtha
Journal:  Neurochem Res       Date:  1994-11       Impact factor: 3.996

9.  Subclassification of presynaptic 5-HT autoreceptors in the human cerebral cortex as 5-HT1D receptors.

Authors:  K Fink; J Zentner; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

10.  In vitro and in vivo activity of 1-(1-naphthyl)piperazine at terminal 5-HT autoreceptors in guinea-pig brain.

Authors:  C Moret; M Briley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.